Cytokinetics, Incorporated (NASDAQ:CYTK) Receives Consensus Recommendation of "Moderate Buy" from Analysts : vimarsana.com

Cytokinetics, Incorporated (NASDAQ:CYTK – Get Free Report) has received a consensus rating of “Moderate Buy” from the fifteen research firms that are currently covering the firm, Marketbeat reports. Two equities research analysts have rated the stock with a hold rating and thirteen have assigned a buy rating to the company. The average 1 year target […]

Related Keywords

, Roberti Blum , Fady Ibraham Malik , Raymond James , Morgan Stanley , Cytokinetics Incorporated , Advisory Services Network , Tower Group , Belpointe Asset Management , Securities Exchange Commission , Needham Company , Get Free Report , Ibraham Malik , Exchange Commission , Asset Management , Services Network , West Tower Group , Get Free , Cytokinetics Daily ,